While there have been some encouraging advances in treating cancer in recent decades, there are still many cancers that either resist treatment or recur after treatment. Today the governing Board of the California Institute for Regenerative Medicine (CIRM) approved investing in a therapy targeting some of these hard-to-treat tumors. BioEclipse Therapeutics Inc. was awarded nearly … Continue reading CIRM invests in therapies that use killer cells to target cancers
cytokines
A look back: CIRM funded trial aims to help patients suffering from chronic viral infections
Dr. Michael Pulsipher All this month we are using our blog and social media to highlight a new chapter in CIRM’s life, thanks to the voters approving Proposition 14. We are looking back at what we have done since we were created in 2004, and also looking forward to the future. Today we look at … Continue reading A look back: CIRM funded trial aims to help patients suffering from chronic viral infections
Treatment for heart failure shows promising results for COVID-19 patients
Dr. Linda Marbán To help with the coronavirus pandemic, many scientists are repurposing previously developed approaches or treatments to see if they can be used to treat patients with COVID-19. Capricor Therapeutics, lead by Dr. Linda Marbán, is using cardiosphere derived cells (CDCs), which are stem cells derived from heart tissue, to treat critically ill … Continue reading Treatment for heart failure shows promising results for COVID-19 patients
Stem cell clinical trial for COVID-19 patients gets emergency federal approval
Dr. Camillo Ricordi, principal investigator of a stem cell trial for COVID-19 at the University of Miami Miller School of Medicine Image Credit: Diabetes Research Institute Foundation Website A team of doctors at the University of Miami (UM) Miller School of Medicine received emergency approval from the U.S. Food and Drug Administration (FDA) to conduct a … Continue reading Stem cell clinical trial for COVID-19 patients gets emergency federal approval